RSV vaccine uptake will start slower than shingles shot: GSK CEO

GSK crushed Pfizer in first round of RSV vaccine showdown

Second Vaccine to Prevent RSV in Older Adults Approved by the FDA - Alliance for Aging Research

GSK Annual-Report-2022, PDF, Vaccines

GSK to up Shingrix vaccine production as demand outstrips supply

RSV vaccine: CDC recommends Pfizer, GSK shots for older adults

Vaccines for Children Program - Wikipedia

GSK signs £2.5bn shingles vaccine deal with China's Zhifei

FDA approves the first-ever RSV vaccine

GSK expects slower uptake of RSV vaccine amid record sales for shingles shot - PharmaLive

What You Should Know About the Shingrix Vaccine for Shingles Prevention

PHARM REPORT: Don't get SHINGLEd out

GSK expects US launch of RSV vaccine with no supply issues

RSV vaccine: CDC panel recommends Pfizer, GSK shots for adults over 60

424B4

Shingrix shingles vaccine protects seniors for 10 years, new data show